Literature DB >> 19283440

Synchronous sigmoid and caecal cancers together with a primary renal cell carcinoma.

A Bhargava1, M O'Callaghan, T Abdelhafiz, P Downey, A Nasr, S Nibhraonain, C Davenport, M G Donovan, P Keeling.   

Abstract

BACKGROUND: Multiple primary neoplasms, a common clinical entity, can be classified as synchronous or metachronous. Renal cell carcinoma, in particular, is associated with a high rate of multiple primary neoplasms.
METHODS: We report a case of a 67-year-old Caucasian woman, who was admitted with history of bleeding per rectum. We conducted a literature review of metachronous and synchronous multiple primary neoplasms.
RESULTS: Colonoscopy revealed a 3 cm tumour in the caecum and a small sigmoid tubulovillous polyp. Staging computed tomography showed a non-enhancing mass in the upper pole of the right kidney. Following a radical nephrectomy/right hemicolectomy, microscopy demonstrated a renal cell carcinoma. Follow-up colonoscopy visualised a mucosal irregularity at the site of the previous sigmoid polyp, with biopsies confirming invasive adenocarcinoma. Patient underwent a total colectomy with an ileo-rectal anastamosis.
CONCLUSION: Multiple primary neoplasms are a well-recognised clinical entity. This report emphasises the need for a comprehensive evidence-based work-up in all cancer cases, especially when dealing with renal cell carcinoma, to look for coexisting metachronous/synchronous primary neoplasms.

Entities:  

Mesh:

Year:  2009        PMID: 19283440     DOI: 10.1007/s11845-009-0298-4

Source DB:  PubMed          Journal:  Ir J Med Sci        ISSN: 0021-1265            Impact factor:   1.568


  8 in total

1.  Multiple primary malignant neoplasms. I. Introduction and presentation of data.

Authors:  C G MOERTEL; M B DOCKERTY; A H BAGGENSTOSS
Journal:  Cancer       Date:  1961 Mar-Apr       Impact factor: 6.860

2.  Multiple primary malignancies in patients with renal cell carcinoma: a national population-based cohort study.

Authors:  Christian Beisland; Olaug Talleraas; August Bakke; Jarle Norstein
Journal:  BJU Int       Date:  2006-04       Impact factor: 5.588

Review 3.  What causes cancer?

Authors:  D Trichopoulos; F P Li; D J Hunter
Journal:  Sci Am       Date:  1996-09       Impact factor: 2.142

4.  Guidelines for colonoscopy surveillance after cancer resection: a consensus update by the American Cancer Society and US Multi-Society Task Force on Colorectal Cancer.

Authors:  Douglas K Rex; Charles J Kahi; Bernard Levin; Robert A Smith; John H Bond; Durado Brooks; Randall W Burt; Tim Byers; Robert H Fletcher; Neil Hyman; David Johnson; Lynne Kirk; David A Lieberman; Theodore R Levin; Michael J O'Brien; Clifford Simmang; Alan G Thorson; Sidney J Winawer
Journal:  CA Cancer J Clin       Date:  2006 May-Jun       Impact factor: 508.702

5.  Renal cell carcinoma guideline.

Authors:  Börje Ljungberg; Damian C Hanbury; Marcus A Kuczyk; Axel S Merseburger; Peter F A Mulders; Jean-Jacques Patard; Ioanel C Sinescu
Journal:  Eur Urol       Date:  2007-03-28       Impact factor: 20.096

6.  Kidney cancer in the Swedish Family Cancer Database: familial risks and second primary malignancies.

Authors:  Kamila Czene; Kari Hemminki
Journal:  Kidney Int       Date:  2002-05       Impact factor: 10.612

7.  Multiple primary malignancies in Japanese patients with renal cell carcinoma.

Authors:  Soshu Sato; Nobuo Shinohara; Shin Suzuki; Toru Harabayashi; Tomohiko Koyanagi
Journal:  Int J Urol       Date:  2004-05       Impact factor: 3.369

8.  Late development of metachronous colorectal cancer.

Authors:  M A Luchtefeld; D S Ross; J D Zander; J R Folse
Journal:  Dis Colon Rectum       Date:  1987-03       Impact factor: 4.585

  8 in total
  1 in total

1.  Multiple Primary Malignancies of the Colon, Stomach, and Kidney in a Patient with Bowel Obstruction Requiring Emergency Surgery: A Case Report.

Authors:  Kholoud H AlBaqmi; Faisal A AlMudaiheem; Sami Boghdadly; Khadijah A AlHussaini; Nada Shokor; Nourah AlOudah
Journal:  Am J Case Rep       Date:  2020-11-27
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.